Many early stage human tumors display markers of a DNA-damage response (DDR), including ataxia telangiectasia mutated (ATM) kinase activation. This suggests that DNA damage accumulates during the process of carcinogenesis and that the ATM-dependent response to this damage may function to suppress cancer progression. The E2F3a transcription factor plays an important role in regulating cell proliferation and is amplified in a subset of human cancers. Similar to human premalignant lesions, we find activated ATM and other markers of the DDR in the hyperplastic epidermis of transgenic mice expressing E2F3a through a keratin 5 (K5) promoter. Primary keratinocytes from K5 E2F3a transgenic mice contain increased levels of DNA breaks compared to wild-type cells. E2F3a overexpression also induced DNA damage in primary human fibroblasts that was inhibited by blocking DNA replication. The absence of ATM impaired apoptosis induced by E2F3a and treating K5 E2F3a transgenic mice with caffeine, an inhibitor of ATM and Rad3-related (ATR), promoted skin tumor development. These findings demonstrate that the deregulated expression of E2F3a causes DNA damage under physiological conditions and indicate that the ATM-dependent response to this damage is important for the induction of apoptosis and tumor suppression.
Introduction
The ataxia telangiectasia mutated (ATM) kinase plays a central role in the cellular response to DNA damage. When activated, ATM phosphorylates a large number of substrates, including itself, the histone variant H2AX (gH2AX), BRCA1, the Chk2 kinase and p53. These ATM-mediated phosphorylation events contribute to the establishment of cell cycle checkpoints and promote DNA repair. In addition, ATM activation can also induce apoptosis or senescence, if DNA damage is persistent. ATM function is best characterized in the response to DNA double-strand breaks but it is now known that ATM can also respond to other types of cellular stress (Bakkenist and Kastan, 2003; Suzuki et al., 2004; Hunt et al., 2007) .
The ATM signaling pathway is activated in many precancerous lesions and early stage cancers from a variety of human tissues (DiTullio et al., 2002; Bartkova et al., 2005; Gorgoulis et al., 2005) . Specifically, these lesions and tumors contain the phosphorylated and activated forms of ATM, Chk2 and p53 and subnuclear foci containing gH2AX and 53BP1. Consistent with this observation, ATM can be activated in cultured cells by the deregulated expression of several oncogenes including E2F1, Ras, Myc, Stat5 and Mos (Powers et al., 2004; Rogoff et al., 2004; Bartkova et al., 2005; Di Micco et al., 2006; Pusapati et al., 2006; Mallette et al., 2007) . Inactivation of the retino-blastoma (Rb) tumor suppressor, which results in the deregulation of endogenous E2F activity, also elicits a DNA-damage response (DDR) (Pickering and Kowalik, 2006; Tort et al., 2006) . The outcome of ATM activation by these oncogenic events is either senescence or apoptosis depending on the oncogene and the experimental context. These findings have led to the suggestion that the ATM pathway functions as a barrier to cancer development by responding to the cellular stress generated by the deregulation of oncogenes in early stage tumors. However, the molecular nature of oncogenic stress, how it arises, and how it is sensed by ATM are issues that remain to be clarified.
The p16-cyclin D-Rb tumor suppressor pathway is disrupted in most human cancers. Rb negatively regulates the activity of several members of the E2F family of transcription factors. E2F3a has been shown to be particularly important for promoting cell proliferation downstream of Rb (Leone et al., 1998; Humbert et al., 2000; Ziebold et al., 2001; Saavedra et al., 2002) and E2F3 gene amplification and overexpression occurs in several types of human cancers (Veltman et al., 2003; Feber et al., 2004; Oeggerli et al., 2004; Grasemann et al., 2005; Orlic et al., 2006) . We recently generated transgenic mice expressing E2F3a in squamous epithelial tissues (Paulson et al., 2006) . K5 E2F3a transgenic mice have hyperplastic and hyperproliferative epidermis and are predisposed to developing spontaneous tumors in the skin and some other K5-positive tissues late in life. Expression of E2F3a also induced apoptosis in transgenic epidermis independent of p53. Here, we use K5 E2F3a transgenic mice as an in vivo model for oncogenic stress in precancerous tissue caused by deregulated E2F activity. We find that transgenic expression of E2F3a leads to the accumulation of DNA breaks and ATM pathway activation. The ATM-dependent response to E2F3a-induced DNA damage leads to apoptosis in transgenic tissues and may be important for suppressing tumor development during the early stages of carcinogenesis.
Results
Transgenic expression of E2F3a leads to DNA damage and ATM activation Previously, we used a transgenic mouse model expressing E2F3a in squamous epithelial tissues to demonstrate that deregulated expression of E2F3a leads to hyperproliferation, apoptosis and spontaneous tumor development (Paulson et al., 2006) . To determine whether transgenic expression of E2F3a, as an oncogenic stress, leads to activation of the ATM DDR pathway, we examined DDR markers in K5 E2F3a transgenic tissue. One of the most widely used markers of DDR is the phosphorylated form of the histone variant H2AX, known as gH2AX (Rogakou et al., 1998) . As a positive control, we treated wild-type mice with ionizing radiation, a potent inducer of doublestrand breaks. No gH2AX foci were observed in untreated wild-type epidermis, while in ionizing radiation -treated epidermis, the formation of gH2AX nuclear foci was readily apparent (Figures 1a and b) . Similar to what is observed in ionizing radiation -treated wild-type tissue, gH2AX foci were also present in untreated K5 E2F3a transgenic epidermis (Figure 1c ).
The ability of E2F3a overexpression to induce gH2AX foci formation was confirmed in primary normal human fibroblast (NHF) cultures infected with a recombinant adenovirus expressing E2F3a (data not shown).
A number of kinases have been reported to phosphorylate H2AX in response to genotoxic stress. To determine the role of the ATM kinase in E2F3a-induced gH2AX foci formation, K5 E2F3a transgenic mice were crossed into an Atm À/À background. In the absence of ATM, gH2AX immunostaining was much reduced in E2F3a transgenic epidermis (Figure 1d ). This indicates that ATM mediates the phosphorylation of H2AX in response to deregulated E2F3a.
Another well-established marker of DDR activation is autophosphorylation of ATM at serine 1981 (Bakkenist and Kastan, 2003) . Western blot analysis using mouse epidermal lysates and a phospho-specific antibody to ATM demonstrated that transgenic expression of E2F3a did indeed lead to ATM phosphorylation at serine 1981 ( Figure 2a ). We also examined phosphorylation of p53 at serine 18, a direct target of ATM, in E2F3a transgenic tissue by immunohistochemistry. As expected, K5 E2F3a transgenic epidermis showed increased staining for phospho-p53 in the basal layer of the epidermis and hair follicles compared to wild-type mice (Figure 2b ). Inactivation of Atm in K5 E2F3a mice eliminated phospho-p53 staining in transgenic tissue.
Overexpression of E2F3a in primary NHFs also induced the autophosphorylation of ATM at serine 1981 and the phosphorylation of p53 at serine 15 (Figure 2c ). This response was similar to the response observed in NHFs treated with the DNA-damaging drug etoposide. As in transgenic tissue, the phosphorylation of p53 in response to ectopic E2F3a expression was dependent on ATM, since it did not occur in primary fibroblasts isolated from an AT patient, which lack functional ATM (Figure 2c ). Taken together, these findings demonstrate that E2F3a overexpression in vivo and in vitro leads to the activation of ATM and the phosphorylation of its downstream targets H2AX and p53.
The ATM kinase plays a pivotal role in the immediate response of cells to double-strand breaks, but it can also
Figure 1 ATM-dependent gH2AX foci formation in the epidermis of K5 E2F3a transgenic mice. Immunofluorescent staining for gH2AX was performed on skin sections from (a) untreated wild-type mice, (b) wild-type mice exposed to 3 Gy of ionizing radiation 20 min before sacrifice, (c) untreated K5 E2F3a transgenic mice and (d) K5 E2F3a transgenic mice null for Atm. ATM, ataxia telangiectasia mutated.
respond to other stresses that do not involve DNA damage (Bakkenist and Kastan, 2003; Suzuki et al., 2004; Hunt et al., 2007) . To determine whether deregulated E2F3a activity causes DNA breaks as the mechanism for activating ATM, we used the single-cell gel electrophoresis (comet) assay. Relatively few primary keratinocytes isolated from wild-type mice exhibited comet tails indicating little DNA damage in these cells (Figure 3a) . In contrast, primary keratinocytes isolated from K5 E2F3a transgenic mice showed an increased percentage of cells with visible comet tails. Calculations of the average olive tail moment, a measure of both the amount and distribution of DNA in the tail, confirmed that E2F3a transgenic keratinocytes had significantly increased DNA damage compared to wild-type keratinocytes ( Figure 3a ). Similar comet assay results were obtained when E2F3a was overexpressed in NHFs using a recombinant adenovirus system ( Figure 3b ).
E2F3a-induced apoptosis is dependent on ATM
The epidermis of K5 E2F3a transgenic mice is hyperproliferative and contains aberrant apoptotic keratinocytes not observed in wild-type mice (Paulson et al., 2006) . To determine how activation of the ATMdependent DDR affects these phenotypes, skin sections from wild-type and K5 E2F3a transgenic mice homozygous or nullizygous for ATM were examined. The increased proliferation observed in K5 E2F3a transgenic epidermis was unaffected by the absence of ATM (Figure 4a ). On the other hand, the increased number of caspase-3-positive cells observed in transgenic epidermis was largely abolished, when Atm was inactivated ( Figure 4b ).
The importance of ATM in E2F3a-induced apoptosis was also tested in primary human cells. NHFs and AT fibroblasts were infected with a control adenovirus vector or with AdE2F3a. As in transgenic epidermis, Figure 2 Overexpression of E2F3a activates ATM. (a) Western blot analysis was performed on epidermal lysates from nontransgenic (lanes 1,2, 5 and 6) or K5 E2F3a transgenic (lanes 3, 4, 7 and 8) mice that were either wild-type (lanes 1-4) or null (lanes 5-8) for Atm. Antibodies specific for E2F3, phospho-ATM S1981 and b-tubulin were used as indicated. (b) Skin sections from wild-type, K5 E2F3a, Atm À/À and K5 E2F3a Atm À/À mice were immunohistochemically stained for the phosphorylated form of p53 (serine 18 in mouse). Positively stained epidermal keratinocytes were identified microscopically and the average number per 10 mm of linear epidermis from at least three mice per group is presented. (c) Western blot analysis was performed on lysates from primary NHFs (lanes 1-3) or primary fibroblasts from an AT patient (lanes 4-6) infected with AdCMV empty vector (lanes 1 and 4), treated with etoposide as a positive control for DNA damage (lanes 2 and 5) or infected with AdE2F3a (lanes 3 and 6). Antibodies specific for E2F3, phospho-p53 S15, phospho-ATM S1981 and b-tubulin were used as indicated. ATM, ataxia telangiectasia mutated; NHFs, normal human fibroblasts. *indicates statistical significance at Po0.05. (a) Primary keratinocytes isolated from the epidermis of newborn wildtype and K5 E2F3a transgenic mice were analyzed in a comet assay. Cells were stained with SYBR Green and images were captured using a fluorescent microscope. The average Olive tail moment (the product of the tail length and fraction of DNA in the tail) was calculated from at least 50 cells for each group. (b) NHFs were infected with AdCMV empty vector or AdE2F3a and cells were subjected to the comet assay as above 24 h post-infection. NHFs, normal human fibroblasts. *indicates statistical significance at Po0.05.
E2F3a overexpression induced a significantly increased level of apoptosis in NHFs, while AT fibroblasts were relatively resistant to the apoptotic effects of E2F3a (Figures 4c and d) . We conclude that E2F3a-induced apoptosis is largely dependent on ATM both in vitro and in vivo.
E2F3a-induced DNA damage is inhibited by aphidicolin It has been suggested that aberrant DNA replication may be responsible for the DNA damage caused by the deregulated expression of oncogenes (Gorgoulis et al., 2005; Bartkova et al., 2006; Di Micco et al., 2006) . To test whether DNA synthesis was required for the DNA damage caused by E2F3a, cells infected with the AdE2F3a vector were treated with the DNA polymerase-a inhibitor, aphidicolin. Aphidicolin did not affect the expression of E2F3a but did inhibit the phosphorylation of H2AX in AdE2F3a-infected cells (Figure 5a ). Consistent with this finding, aphidicolin dramatically reduced DNA damage induced by AdE2F3a infection as measured by the comet assay (Figure 5b ). This indicates that at least some DNA replication is involved in the generation of DNA damage caused by E2F3a overexpression.
Caffeine promotes skin tumorigenesis in E2F3a transgenic mice It has been suggested that the ATM pathway functions to suppress tumorigenesis by responding to oncogenic stress and promoting senescence and/or apoptosis (Bartkova et al., 2005; Gorgoulis et al., 2005) . To directly test the role of ATM in suppressing E2F3a-driven tumorigenesis, we generated and maintained K5 E2F3a transgenic mice in an Atm À/À background. However, Atm À/À mice rapidly develop thymic lymphomas and thus we were unable to observe cooperation between ATM loss and E2F3a overexpression in the promotion of epithelial tumors.
As an alternative approach to inactivating ATM, caffeine was given to K5 E2F3a transgenic mice to inhibit ATM and ATR kinase activities. This approach was recently used by Bartkova et al. (Bartkova et al. , 2006) to inhibit the DDR in Ras-expressing cells, which led to larger and more invasive tumors in a xenograft mouse model. K5 E2F3a transgenic and wild-type sibling mice were given caffeine in their drinking water at a final concentration of 0.4 mg/ml beginning shortly after weaning.
Treatment of K5 E2F3a mice with caffeine suppressed the DDR as indicated by reduced gH2AX foci formation in the nuclei of transgenic epidermal keratinocytes (Figure 6a ). Approximately half of the K5 E2F3a mice given caffeine developed visible skin lesions after several months of treatment, with several mice developing multiple lesions (Table 1) . Skin lesions did not develop in untreated K5 E2F3a transgenic mice or in wild-type mice given caffeine. Histopathological analysis of several of these lesions showed them to be well differentiated tumors probably arising from the infundibular region of the hair follicle. These tumors have several characteristics of human keratoacanthoma, including large keratin cysts and in some cases signs of invasiveness (Figure 6b ). Also like keratoacanthomas, these tumors grew rapidly up to a point and then stopped, often spontaneously regressing after several weeks. Taken together, these findings provide additional support for the idea that ATM can suppress tumorigenesis at an early stage by responding to oncogene-induced DNA damage.
Discussion
Analysis of K5 E2F3a transgenic mice demonstrates that the deregulated expression of E2F3a, which occurs in some human cancers, leads to the accumulation of DNA breaks under physiological conditions. Previously, we demonstrated that transgenic expression of Myc caused DNA breaks in a similar mouse model (Pusapati et al., 2006) . This suggests that the accumulation of DNA damage may be a common feature of oncogeneexpressing cells and tissues. Indeed, we have observed markers of DNA damage in transgenic mice expressing other oncogenes, such as SV40 T antigen and human papilloma virus E7, in several different tissues (R Pusapati, unpublished results). These results are consistent with observations from the analysis of early stage human cancers, which often display markers of DNA damage before the onset of widespread genetic instability (Bartkova et al., 2005; Gorgoulis et al., 2005) .
A number of possibilities have been suggested for how oncogenes might cause DNA damage, including the production of reactive oxygen species, telomere attrition and replication stress. Our finding that aphidicolin can block the accumulation of DNA breaks in E2F3a overexpressing cells agrees with several other reports implicating aberrant replication in oncogene-induced DNA damage Di Micco et al., 2006) . One possibility is that E2F3a as well as some other oncogenes cause DNA damage by promoting illegitimate replication origin firing (refiring). A model for how replication origin refiring could lead to DNA breaks through replication fork collision has recently been proposed by Blow and colleagues (Davidson et al., 2006) . The DNA damage caused by E2F3a overexpression results in the activation of ATM and this is important for the induction of apoptosis. E2F3a-induced apoptosis is significantly reduced by the absence of ATM in transgenic mouse tissue and in primary human fibroblasts. These results are similar to our previous findings demonstrating that ATM is critical for apoptosis induced by Myc and E2F1 (Powers et al., 2004; Pusapati et al., 2006) . Although we use p53 phosphorylation as an indication of ATM pathway activation, we have shown that the absence of p53 has no effect on E2F3a-induced apoptosis (Paulson et al., 2006) . This suggests that one or more other targets of ATM are important for apoptosis induced by E2F3a. Other groups have 1 and 2) or AdE2F3a (lanes 3 and 4) in the absence (lanes 1 and 3) or presence (lanes 2 and 4) of aphidicolin (5 mg/ml). Antibodies specific for E2F3, gH2AX, and glyceraldehyde 3 phosphate dehydrogenase (GAPDH) were used as indicated. Images for each primary antibody are from the same blot and exposure with irrelevant, internal lanes removed. (b) NHFs infected with AdCMV control virus or AdE2F3a were untreated or exposed to aphidicolin (5 mg/ml) at the time of infection. 24 h post-infection, cells were subjected to the comet assay and the average Olive tail moment was calculated as previously described. NHFs, normal human fibroblasts.
recently shown that cellular senescence induced by the deregulated expression of oncogenes such as Ras is also dependent on ATM Di Micco et al., 2006; Mallette et al., 2007) . Thus, ATM appears to be critical for responding to oncogenic stress generated by a variety of oncogenes and can promote either apoptosis or senescence depending on the context. Bartkova and coworkers recently demonstrated that caffeine in the drinking water can inhibit ATM activation and stimulate the development of larger and more invasive tumors using a Ras-driven xenograft mouse model. Interestingly, the dose of caffeine (approximately 15 mg/kg/day) used in that experiment is physiologically relevant and similar to the amount consumed by a heavy coffee drinker (Mandel, 2002) . Similar to those findings, we found that the same concentration of caffeine also promoted de novo tumorigenesis in K5 E2F3a transgenic mice. These skin tumors appeared to arise from the infundibular portion of the hair follicle and had a number of similarities to human keratoacanthomas. Some of these lesions had features of well-differentiated squamous cell carcinoma with signs of invasion, while others had features of sessile (broad based) skin papillomas. However, in all cases, there was abundant keratin accumulation and most lesions appeared connected with hair follicles. The rapid appearance, lack of progression and frequent spontaneous regression of these lesions are also behaviors reminiscent of human keratoacanthomas (Karaa and Khachemoune, 2007) . The fact that these tumors in caffeine-treated transgenic mice do not progress and often regress suggests that there are additional, backup tumor suppressive mechanisms that respond to increased E2F3a activity in addition to ATM.
There is growing evidence that ATM not only functions as a tumor suppressor in AT patients and carriers but also in the general population. Recent genomic analyses of a variety of human cancers found that somatic mutations in ATM are relatively common and appear to be a driving force in tumorigenesis (Davies et al., 2005; Greenman et al., 2007) . Silencing of ATM gene expression by promoter hypermethylation has also been shown to frequently occur in several human cancers (Ai et al., 2004; Vo et al., 2004; Safar et al., 2005) . Kinzler and Vogelstein (Kinzler and Vogelstein, 1997) originally classified tumor suppressors into two main categories: gatekeepers and caretakers. Gatekeepers act as tumor suppressors by directly controlling cell proliferation or survival while caretakers function by maintaining the integrity of the genome, thus preventing the accumulation of cancer-driving mutations. It is widely assumed that ATM, as a major mediator of the DDR, functions as a caretaker by maintaining genomic stability. However, our findings and those of others suggest that ATM may also function as a gatekeeper by directly responding to oncogeneinduced DNA damage and inducing either apoptosis or senescence in oncogene-expressing cells. The observation that the ATM DDR is activated in many early stage tumors suggests that ATM might play this caretaker role quite frequently to prevent premalignant lesions from progressing to malignant cancer. 
Materials and methods
Mice and treatments K5 E2F3a transgenic mice have been described and are in the FVB strain background (Paulson et al., 2006) . The Atm null allele has been described (Barlow et al., 1996) . Atm þ /À mice were originally obtained from the Jackson Laboratory and at the time of use were in a mixed strain background. Sibling mice of different genotypes were used for comparison in all experiments. Caffeine was obtained from Sigma Chemical Co. and dissolved in deionized autoclaved water at a concentration of 0.4 mg/ml. Mice were given free access to water with caffeine shortly after weaning and treatment continued for up to 6 months, changing the water weekly.
Cells and viruses
Primary NHFs and AT fibroblasts (Coriell Cell Repositories) were maintained in modified Eagles media (MEM) with 2 mM glutamine, nonessential amino acids and 15% fetal bovine serum. Recombinant adenovirus expressing human E2F3a was made using the AdEasy Kit (Quantum Biotechnologies, East Hampstead, NH, USA). For infections, cells were washed, counted and cultured in 10 cm plates in 3 ml of serum-free medium containing adenovirus vectors at a multiplicity of infection of 100. After 1 h of infection, 7 ml of media with 0.5% fetal bovine serum was added and cells incubated for an additional 24 h for the comet assay or 48 h for the apoptosis assay and immunoblotting. Aphidicolin (Sigma Chemical Co., St Louis, MO, USA) was added to cell media at a final concentration of 5 mg/ml at the time of infections.
Immunofluorescence and immunohistochemistry
Immunofluorescent staining for gH2AX (H2AX pS139, Millipore, Danvers, MA, USA, 1: 300 dilution) in formalinfixed, paraffin-embedded mouse skin sections was performed as described previously (Pusapati et al., 2006) . Activated caspase-3 immunostaining (R&D Systems, Minneapolis, MN, USA, 1:2 000 dilution) was performed on mouse skin sections as described (Russell et al., 2002) . Bromodeoxyuridine incorporation was detected in mouse skin sections using an antibody to bromodeoxyuridine (Becton Dickinson, Franklin Lakes, NJ, USA, 1:500 dilution) and epidermal proliferation was scored as described previously (Paulson et al., 2006) . Immunostaining for phosphorylated p53 (mouse serine 18) was performed on formalin-fixed, paraffin-embedded sections. After deparaffinizing, rehydrating and blocking endogenous peroxidase activity antigen was retrieved by microwaving slides in 10 mM citrate buffer, pH 6.0, for 15 min on high plus 5 min on 50% power. Slides were treated with blocking reagent (Biocare, Concord, CA, USA) and incubated with antibody specific for phospho-p53 S15 (Cell signaling Technologies, Danvers, MA, USA, 1:100 dilution) for 2 h. After washing, slides were incubated with secondary anti-rabbit HRP (Dako, Carpinteria, CA, USA) for 30 min and stained using DAB reagent (Dako).
Western blot analysis
Epidermal protein was collected as described previously (Paulson et al., 2006) . The following antibodies were used to detect the indicated protein: phospho-ATM S1981 (Rockland, Gilbertsville, PA, USA), E2F3 (Santa Cruz Biotechnology, C-18), b-tubulin (Santa Cruz Biotechnology, Santa Cruz, CA, USA, H-235), phospho-p53 S15 (Cell Signaling Technology), b-actin (Santa Cruz Biotechnology, H-2350).
Caspase-3 apoptosis assay Caspase-3 activity was measured in cell lysates using the fluorogenic peptide substrate acetyl-DEVD-AFC (Biomol Research Laboratories, Plymouth Meeting, PA, USA) per manufacturer's protocol. Production of 7-amino-4-trifluoromethyl coumarin (AFC) was measured in a spectrofluorimeter with an excitation wavelength of 400 nm and an emission wavelength of 505 nm.
Single-cell gel electrophoresis (comet) assay Primary keratinocytes from dorsal skin samples were isolated and subjected to the Comet assay (Trevigen, Gaithersburg, MD, USA) as described previously (Pusapati et al., 2006) . A similar procedure was used on NHFs infected with AdE2F3a or AdCMV empty vector 24 h post-infection. Olive tail moments, a measurement of the extent of DNA damage, were calculated for at least 50 cells per slide using the COMET-SCORE software (TriTek).
